Brandon W Fenn


+1 212 479 6626

Brandon Fenn is an associate in the emerging companies and venture capital practice groups. He represents venture capital funds and technology, biotechnology, medical device and other high-growth companies. His practice includes mergers and acquisitions, venture capital financings, public offerings and general corporate counseling.

Download full bio


  • Innate Pharma - $79 Million IPO 

  • Workframe Sells to Newmark Group 

  • Nuvolo Closes $12 Million Series B 

  • Therachon Sells to Pfizer for up to $810 Million 

  • Formation of Group Nine Media 

  • View all


  • New York University School of Law
    JD, 2010

  • Dartmouth College
    BA, 2007

Admissions & Credentials


New York


+1 212 479 6626 office

55 Hudson Yards
New York, NY 10001-2157